Gardasil 9
Payments companies reported to CMS as associated with Gardasil 9. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gardasil 9, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gardasil 9
These are the largest totals companies reported as associated with Gardasil 9. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Stephen Goldstone | Ny, NY | Surgery | $136,040.10 |
| Kenneth Alexander | Orlando, FL | Infectious Disease | $61,701.22 |
| Robert Kurman | Baltimore, MD | Anatomic Pathology & Clinical Pathology | $45,662.00 |
| Brigitte Ronnett | Baltimore, MD | Anatomic Pathology & Clinical Pathology | $42,803.64 |
| Mark Stoler | Charlottesville, VA | Anatomic Pathology | $40,776.72 |
| Martha Bowden | Memphis, TN | Adolescent Medicine (Pediatrics) | $22,220.33 |
| Bruce Wenig | Tampa, FL | Anatomic Pathology | $21,381.82 |
| Anna Moscicki | San Francisco, CA | Pediatrics | $11,129.23 |
| Rebecca Perkins | Boston, MA | Obstetrics & Gynecology | $9,785.00 |
| Elba Diaz Toro | Carolina, PR | Prosthodontics | $9,560.08 |
Prescribed Gardasil 9?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.